The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Hypertension

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.HJH.0000133730.47372.4CPMID 15257185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [O2‐01‐07]: Does vitamin E use protect against dementia or increase the risk of mortality?

  2005cited by this paper
• The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

  2003cited by this paper
• Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?

  2002cited by this paper
• Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline Characteristics

  2000cited by this paper
• [The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension].

  2000cited by this paper
• Guidelines for the management of hypertension.

  2000cited by this paper
• Study on COgnition and Prognosis in the Elderly (SCOPE).

  1999cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.

  1997cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results.

  1992cited by this paper
• Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

  1992cited by this paper
• Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

  1991cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.

  1989cited by this paper
• Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.

  1989cited by this paper
• Survival analysis: A practical approach

  1989cited by this paper
• Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial

  1986cited by this paper
• Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

  1985cited by this paper
• Letter: Immunotherapy for colorectal cancer.

  1976cited by this paper

• Comparative efficacy of different antihypertensive drug classes for stroke prevention: A network meta-analysis of randomized controlled trials

  2025cites this paper
• Challenges in developing Geroscience trials

  2023cites this paper
• Angiotensin Receptor Blockers and Cognition: a Scoping Review

  2023cites this paper
• Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization

  2022influential citation
• Hypertension in older people

  2022cites this paper
• Starting Antihypertensive Drug Treatment With Combination Therapy

  2021cites this paper
• Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results.

  2021cites this paper
• Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-analysis.

  2021cites this paper
• Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.

  2021cites this paper
• Hypertension treatment in elderly patients in 2019: well-known, hot-topics and surprises

  2020cites this paper
• Особенности лечения артериальной гипертонии у пожилых пациентов в 2019 году. Об общеизвестном, дискутабельном и неожиданном

  2020cites this paper
• Hypertension and Pathogenic hAPP Independently Induce White Matter Astrocytosis and Cognitive Impairment in the Rat

  2020cites this paper
• Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease

  2020cites this paper
• Hypertension in the Elderly

  2019cites this paper
• Atherosclerosis, Hypertension, and Diabetes in Alzheimer’s Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation

  2018cites this paper
• Management of hypertension in older people

  2018cites this paper
• White Matter Inflammation And Executive Dysfunction: Implications For Alzheimer Disease And Vascular Cognitive Impairment

  2018cites this paper
• High blood pressure: An obscuring misnomer?

  2016cites this paper
• Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production

  2015cites this paper
• Vascular Cognitive Impairment, Part 2 Cognitive impairment after acute stroke is likely under-appreciated despite its impact.

  2015cites this paper
• ARB-Based Single-Pill Platform to Guide a Practical Therapeutic Approach to Hypertensive Patients

  2014cites this paper
• Drug Safety and Effectiveness Network Report: A Systematic Review with Network Meta-Analyses and Economic Evaluation Comparing Therapies for Hypertension in Non-Diabetic Patients

  2014cites this paper
• The evidence for treating hypertension in older people with dementia: a systematic review

  2014cites this paper
• RESIDUAL RISK AND RESISTANCE TO THE BENEFITS OF ANTIHYPERTENSIVE TREATMENT

  2014cites this paper
• Association between blood pressure and disability-free survival among community-dwelling elderly patients receiving antihypertensive treatment

  2014cites this paper
• Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.

  2013cites this paper
• Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

  2013cites this paper
• Association Healthcare Professionals From the American Heart Association/American Stroke Vascular Contributions to Cognitive Impairment and Dementia : A Statement for

  2013cites this paper
• Cognition and Hemodynamics

  2012cites this paper
• Candesartan Cilexetil

  2012cites this paper
• Losartan

  2012cites this paper
• Higher cardiovascular risk and impaired benefit of antihypertensive treatment in hypertensive patients requiring additional drugs on top of randomized therapy: is adding drugs always beneficial?

  2012cites this paper
• Necessity of add-on therapy in the treatment of hypertension: a new marker of high cardiovascular risk?

  2012cites this paper
• High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension

  2011cites this paper
• AHA / ASA Scientific Statement Vascular Contributions to Cognitive Impairment and Dementia

  2011cites this paper
• Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update

  2011cites this paper
• Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2011cites this paper
• The frail renin-angiotensin system.

  2011cites this paper
• Vascular Contributions to Cognitive Impairment and Dementia : A Statement

  2011cites this paper
• Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.

  2010cites this paper
• Quality of Life, Drugs and Diet in Hypertensive Patients

  2010cites this paper
• Europejskie zalecenia dotyczące leczenia nadciśnienia tętniczego: stanowisko Europejskiego Towarzystwa Nadciśnienia Tętniczego 2009

  2010cites this paper
• A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials

  2010cites this paper
• Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia.

  2010cites this paper
• Toole's Cerebrovascular Disorders: Hematological Disorders and Hypercoagulable States

  2010cites this paper
• Hypertension and cognitive function in the elderly.

  2010cites this paper
• Patient adherence in the treatment of hypertension: the role of combination therapies.

  2010cites this paper
• The unsolved relationship of brain aging and late-onset Alzheimer disease.

  2009cites this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

  2009cites this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

  2009cites this paper
• The heart frequency and its variability in hypertensive patients considering A/B type of behaviour and eight basic emotions and levels of anger expression.

  2009cites this paper
• Blocking the renin–angiotensin system: dual- versus mono-therapy

  2009cites this paper
• Identification of Antihypertensive Drugs Which Inhibit Amyloid-β Protein Oligomerization

  2009cites this paper
• [Essential hypertension, dementia, and antihypertensive therapy in geriatric patients].

  2009cites this paper
• [CASE-J: a large-scale clinical trial in hypertensive patients].

  2009cites this paper
• Current Concepts in Vascular Cognitive Impairment and Pharmacotherapeutic Implications

  2009cites this paper
• Blood pressure, antihypertensive treatment and cognitive decline in older adults

  2009cites this paper
• Aerobic Exercise, Diet, and Neurocognition among Individuals with High Blood Pressure

  2009cites this paper
• Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.

  2009cites this paper
• 4．CASE-J（高血圧に関する大規模臨床試験）

  2009cites this paper
• Use of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy to reduce cardiovascular events in high-risk patients: Part 1.

  2008cites this paper
• The Importance of Prompt Blood Pressure Control

  2008cites this paper
• Not only the effective, but a rapid blood pressure reduction as a novel aim in hypertension treatment. The role of combination therapy

  2008cites this paper
• Aegis against Stroke and Dementia by Angiotensin Type 1 Receptor Blockers: New Beneficial Aspects

  2008cites this paper
• Diabetes :A Paradigm and its Prevention

  2008cites this paper
• The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential.

  2008cites this paper
• Effects of Antihypertensive Drug Treatment on the Risk of Dementia and Cognitive Impairment

  2008cites this paper
• Candesartan: from left ventricular hypertrophy to heart failure, a global approach

  2007cites this paper
• Reducing diabetes incidence through the inhibition of the renin–angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?

  2007cites this paper
• Management of hypertension in diabetes mellitus

  2007cites this paper
• Role of angiotensin receptor blockers in the prevention and management of ischaemic stroke

  2007cites this paper
• Hypertension and cognitive function in the elderly.

  2007cites this paper
• Angiotensin II Receptor Antagonists

  2007cites this paper
• Reading and citing from the Journal of Hypertension.

  2007cites this paper
• Vascular cognitive change: Perspective from neurology

  2007cites this paper
• Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.

  2007cites this paper
• Chapter 48 – The Brain in Hypertension

  2007cites this paper
• Blood pressure treatment and cognition in the elderly.

  2007cites this paper
• Hypertension, cognitive decline, and dementia: an epidemiological perspective

  2007cites this paper
• Candesartan cilexetil – a review of effects on cardiovascular complications in hypertension and chronic heart failure

  2007cites this paper
• New-onset diabetes and antihypertensive drugs.

  2006cites this paper
• [Risk factors for Alzheimer: towards prevention?].

  2006cites this paper
• Prevención de la diabetes mellitus en los pacientes con insuficiencia cardiaca

  2006cites this paper
• The NIH Cognitive and Emotional Health Project

  2006cites this paper
• Sekundärprävention nach ischämischem Schlaganfall: Ein aktualisierter Überblick

  2006cites this paper
• Cardiac risk factors and potential treatments in Alzheimer's disease

  2006cites this paper
• Facteurs de risque de la maladie d’Alzheimer: vers une prévention?

  2006cites this paper
• The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease.

  2006cites this paper
• Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) – A review

  2006cites this paper
• Cerebrovascular prevention by angiotensin II receptor antagonists

  2006cites this paper
• Cardiovascular disease and Alzheimer's disease: common links

  2006cites this paper
• Changing concepts on the role of blood pressure reduction in cardiovascular prevention

  2006cites this paper
• Antihypertensive drug treatment and cardiovascular prevention : an update including the 2003–2004 secondary prevention trials

  2006cites this paper
• The Study on COgnition and Prognosis in the Elderly (SCOPE) – recent analyses

  2006cites this paper
• The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease.

  2006cites this paper
• The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial: Outcomes in Patients Receiving Monotherapy

  2006cites this paper
• Treating vascular risk factors and maintaining vascular health: Is this the way towards successful cognitive ageing and preventing cognitive decline?

  2006cites this paper
• [Arterial hypertension and the brain].

  2006cites this paper
• Antihypertensive therapy and cerebrovascular protection

  2006cites this paper
• The age-dependent relation of blood pressure to cognitive function and dementia.

  2005cites this paper